United Therapeutics | UTHR - Equity Capital And Reserves


United Therapeutics reported $6.59B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Amarin USD 458.89M 6.03M Sep/2025
Ardelyx USD 154.28M 14.75M Sep/2025
Baxter International USD 7.24B 79M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
GlaxoSmithKline GBP 16.15B 1.79B Sep/2025
Halozyme Therapeutics USD 503.92M 171.17M Sep/2025
Insmed USD 945.57M 304.16M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
J&J USD 78.47B 0 Sep/2025
Moderna USD 9.33B 69M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
PTC Therapeutics USD -155.76M 50.79M Sep/2025
Regeneron Pharmaceuticals USD 30.96B 1.02B Sep/2025
Sarepta Therapeutics USD 1.32B 37.26M Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025
United Therapeutics USD 6.59B 583.4M Sep/2025
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025